Cite
MLA Citation
Maryam Fouladi et al.. “A phase I trial of MK‐2206 in children with refractory malignancies: A Children's Oncology Group study.” Pediatric blood & cancer, vol. 61, no. 7, n.d., pp. 1246–1251. http://access.bl.uk/ark:/81055/vdc_100025085692.0x000016